These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24972007)

  • 1. Small rigid platforms functionalization with quaternary ammonium: targeting extracellular matrix of chondrosarcoma.
    Miot-Noirault E; Vidal A; Morlieras J; Bonazza P; Auzeloux P; Besse S; Dauplat MM; Peyrode C; Degoul F; Billotey C; Lux F; Rédini F; Tillement O; Chezal JM; Kryza D; Janier M
    Nanomedicine; 2014 Nov; 10(8):1887-95. PubMed ID: 24972007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept.
    Peyrode C; Weber V; Voissière A; Maisonial-Besset A; Vidal A; Auzeloux P; Gaumet V; Borel M; Dauplat MM; Quintana M; Degoul F; Rédini F; Chezal JM; Miot-Noirault E
    Mol Cancer Ther; 2016 Nov; 15(11):2575-2585. PubMed ID: 27573424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma.
    Miladi I; Vivier M; Dauplat MM; Chatard M; Besse S; Vidal A; Chassain K; Jean B; Forestier C; Chezal JM; Rédini F; Degoul F; Miot-Noirault E
    Cancer Chemother Pharmacol; 2017 Sep; 80(3):517-526. PubMed ID: 28707014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaternary ammonium-melphalan conjugate for anticancer therapy of chondrosarcoma: in vitro and in vivo preclinical studies.
    Peyrode C; Weber V; David E; Vidal A; Auzeloux P; Communal Y; Dauplat MM; Besse S; Gouin F; Heymann D; Chezal JM; Rédini F; Miot-Noirault E
    Invest New Drugs; 2012 Aug; 30(4):1782-90. PubMed ID: 21499733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship study of hypoxia-activated prodrugs for proteoglycan-targeted chemotherapy in chondrosarcoma.
    Ghedira D; Voissière A; Peyrode C; Kraiem J; Gerard Y; Maubert E; Vivier M; Miot-Noirault E; Chezal JM; Farhat F; Weber V
    Eur J Med Chem; 2018 Oct; 158():51-67. PubMed ID: 30199705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteoglycan-targeting applied to hypoxia-activated prodrug therapy in chondrosarcoma: first proof-of-concept.
    Voissiere A; Weber V; Gerard Y; Rédini F; Raes F; Chezal JM; Degoul F; Peyrode C; Miot-Noirault E
    Oncotarget; 2017 Nov; 8(56):95824-95840. PubMed ID: 29221170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swarm chondrosarcoma: a continued resource for chondroblastic-like extracellular matrix and chondrosarcoma biology research.
    Stevens JW
    Connect Tissue Res; 2013; 54(4-5):252-9. PubMed ID: 23758266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5'-methylschweinfurthin G reduces chondrosarcoma tumor growth .
    Stevens JW; Meyerholz DK; Neighbors JD; Morcuende JA
    J Orthop Res; 2018 Apr; 36(4):1283-1293. PubMed ID: 28960476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Swarm rat chondrosarcoma cells as an in vivo model: lung colonization and effects of tissue environment on tumor growth.
    Morcuende JA; Stevens JW; Scheetz TE; de Fatima Bonaldoc M; Casavant TL; Otero JE; Soares MB
    Iowa Orthop J; 2012; 32():46-53. PubMed ID: 23576921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of targeted hypoxia-activated prodrugs applied to chondrosarcoma chemotherapy.
    Gerard Y; Voissière A; Peyrode C; Galmier MJ; Maubert E; Ghedira D; Tarrit S; Gaumet V; Canitrot D; Miot-Noirault E; Chezal JM; Weber V
    Bioorg Chem; 2020 May; 98():103747. PubMed ID: 32208207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacokinetic profile of a quaternary ammonium derivative of chlorambucil, a potential anticancer drug for the chemotherapy of chondrosarcoma.
    Rapp M; Giraud I; Maurizis JC; Madelmont JC
    Bioorg Med Chem; 2003 Nov; 11(23):5007-12. PubMed ID: 14604663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proof of Concept of the Radiosensitizing Effect of Gadolinium Oxide Nanoparticles in Cell Spheroids and a Tumor-Implanted Murine Model of Chondrosarcoma.
    Aloy MT; Sidi Boumedine J; Deville A; Kryza D; Gauthier A; Brichart-Vernos D; Ollier G; La Padula V; Lux F; Tillement O; Rodriguez-Lafrasse C; Janier M
    Int J Nanomedicine; 2022; 17():6655-6673. PubMed ID: 36582458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracer.
    Miot-Noirault E; Gouin F; Vidal A; Rapp M; Maublant J; Askienazy S; Chezal JM; Heymann D; Redini F; Moins N
    J Nucl Med; 2009 Sep; 50(9):1541-7. PubMed ID: 19690026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticles.
    Morlieras J; Chezal JM; Miot-Noirault E; Vidal A; Besse S; Kryza D; Truillet C; Mignot A; Antoine R; Dugourd P; Redini F; Sancey L; Lux F; Perriat P; Janier M; Tillement O
    Chem Commun (Camb); 2013 Apr; 49(29):3046-8. PubMed ID: 23467614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hyaluronan synthesis attenuates the tumorigenicity of low-grade chondrosarcoma.
    Hamada S; Nishida Y; Zhuo L; Shinomura T; Ikuta K; Arai E; Koike H; Kimata K; Ushida T; Ishiguro N
    J Orthop Res; 2018 Jun; 36(6):1573-1580. PubMed ID: 29091320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced expression of KIAA1199, a novel hyaluronidase, inhibits tumorigenicity of low-grade chondrosarcoma.
    Koike H; Nishida Y; Shinomura T; Zhuo L; Hamada S; Ikuta K; Ito K; Kimata K; Ushida T; Ishiguro N
    J Orthop Res; 2020 Sep; 38(9):1942-1951. PubMed ID: 32068299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered synthesis of cartilage-specific proteoglycans by mutant human cartilage oligomeric matrix protein.
    Kwak YH; Roh JY; Lee KS; Park HW; Kim HW
    Clin Orthop Surg; 2009 Dec; 1(4):181-7. PubMed ID: 19956474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microenvironment alters epigenetic and gene expression profiles in Swarm rat chondrosarcoma tumors.
    Hamm CA; Stevens JW; Xie H; Vanin EF; Morcuende JA; Abdulkawy H; Seftor EA; Sredni ST; Bischof JM; Wang D; Malchenko S; Bonaldo Mde F; Casavant TL; Hendrix MJ; Soares MB
    BMC Cancer; 2010 Sep; 10():471. PubMed ID: 20809981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versican V1 isoform regulates cell-associated matrix formation and cell behavior differentially from aggrecan in Swarm rat chondrosarcoma cells.
    Wasa J; Nishida Y; Shinomura T; Isogai Z; Futamura N; Urakawa H; Arai E; Kozawa E; Tsukushi S; Ishiguro N
    Int J Cancer; 2012 May; 130(10):2271-81. PubMed ID: 21671478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.
    Morlieras J; Dufort S; Sancey L; Truillet C; Mignot A; Rossetti F; Dentamaro M; Laurent S; Vander Elst L; Muller RN; Antoine R; Dugourd P; Roux S; Perriat P; Lux F; Coll JL; Tillement O
    Bioconjug Chem; 2013 Sep; 24(9):1584-97. PubMed ID: 23978076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.